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Background: Rheumatoid arthritis is a chronic inflammatory condition that affects the joints causing unpredictable
episodes of pain, stiffness and disability. People with rheumatoid arthritis usually require lifelong specialist follow-up
but frequently have periods when their disease can be managed through self-care or that provided by their
general practitioner. Compared to the traditional clinician-driven care in rheumatoid arthritis, patient-initiated care
has proven to be more beneficial in terms of reducing unnecessary medical reviews, providing greater satisfaction
to patients and staffs and maintaining the patient’s physical and psychological status. We aim to evaluate the
implementation of a patient-initiated review system in a routine secondary care rheumatology service in a public
hospital in England, where patients get the opportunity to self-manage their disease by requesting specialist
reviews at times of need instead of clinician-scheduled appointments.
Methods/design: Three hundred and eighty patients attending routine review at Plymouth Hospitals NHS Trust
will be randomised to either enrol immediately into a patient-initiated review system (direct access group), or to be
seen regularly by a clinician at the hospital (regular clinician-initiated group). Patients (or their general practitioner)
in the direct access group can arrange a review by calling a rheumatology nurse-led advice line that enables
telephone delivered clinical advice, or where appropriate, an appointment with a rheumatologist within 10 working
days. Patients in the regular clinician-initiated group will attend their planned appointments at regular intervals
during the intervening period of 12 months. The primary outcome of interest is patient satisfaction; secondary
outcomes include service use, waiting times and clinical measures. Semi-structured, in-depth interviews will be
conducted with a subset of patients and staff with the aim of identifying facilitators/barriers in implementing
patient-initiated clinics.
Discussion: The implementation of a patient-initiated review system in routine care rheumatology will replace the
fixed clinician-driven review system with a more flexible patient-driven system where patients usually self-manage
their disease, but can request prompt help when required. We believe that this study will enable a comparison of
the changes in local services and will be helpful in exploring the benefits/drawbacks of such implementation, thus
providing lessons for implementation in other hospitals and for other chronic diseases.* Correspondence: priya.paudyal@pcmd.ac.uk
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Rheumatoid arthritis (RA) is a chronic disease that pri-
marily affects the synovial joints causing unpredictable
episodes of joint pain, stiffness and swelling. There are
approximately 400,000 people with RA in the United
Kingdom (UK), with around 15 men and 36 women
developing RA per 100,000 people per year [1]. It has
been estimated that the total cost associated with RA in
the UK, including indirect costs and work-related dis-
ability is between £3.8 and £4.75 billion per year [1].
People with RA often have lifelong symptoms that fluc-
tuate on a daily or longer basis, intermittent disease
flares, and an unpredictable long-term outcome. Hence,
these patients need to develop the skills to manage their
own condition and its consequences on their lives [2].
In the UK, the majority of people with RA are mana-
ged by routine medical review initiated by the hospital
rheumatologist or rheumatology specialist nurse every
3–6 months. However, this traditional system of review
may lead to a mismatch between clinical need and clin-
ical input. Patients are often seen on a date determined
some time in advance, and review may occur when the
patient is well rather than during periods of exacerbation
[2]. A previous study into the content of routine reviews
of patients with RA reported that 30% of routine
appointments resulted in no investigations or other ac-
tion; 35% were seen to be problem free; and 42% were
thought to be unnecessary [3]. Hence, it is likely that
considerable hospital out-patient time and resources are
wasted on the one hand and on the other hand the sys-
tems of review may be unresponsive at the times when
patients need them most.
A randomised controlled trial (RCT) conducted in
Bristol, UK, compared traditional 3–6 monthly
rheumatologist-initiated review with patient-initiated re-
view alone [4-6]. This trial reported that patient-initiated
reviews maintained the patient’s physical and psycho-
logical status but reduced unnecessary medical reviews
by at least a third, thus making more efficient use of fi-
nite resources. The trial data also showed that patients
and GPs had more confidence and satisfaction in such a
system when compared to clinician- driven follow-up.
Numerous studies looking at the impact of open access
patient-initiated follow-up clinics in patients with med-
ical conditions such as lung cancer [7], breast cancer [8],
diabetes [9], urinary tract infections [10], gastroscopy
[11] and endoscopy [12] have also reported positive
effects resulting from such clinics in terms of patient care
and satisfaction, cost-effectiveness and efficiency.
The National Institute for Health and Clinical Excel-
lence (NICE) guidelines for RA recommend that people
with satisfactorily controlled established RA should be
able to review the frequency of their appointments at a
location suitable to them and in addition, make surethey have access to additional visits for disease flares and
know when and how to get rapid access to specialist
care [1]. Similarly, The British Society for Rheumatology
(BSR) guidelines state that patients need an individua-
lised management plan including choices for long-term
follow-up care, and self-initiated access to primary or
secondary care including telephone advice [13]. These
guidelines support the need for systems that promote
self-management of care and treatment in patients
with RA.
Given the evidence from the trial by Hewlett and col-
leagues [6], and the recommendations from NICE and
BSR, we decided to implement a patient-initiated review
system at Plymouth Hospitals NHS Trust (PHNT) in
the UK. The Trust currently has a clinician-driven,
overwhelmed and delayed outpatient follow up system
for people with RA. We believe that the introduction of
this evidence based review system will help to empower
patients and provide them with the opportunity to self-
manage the disease through the ability to request their
own prompt specialist review when required.
Methods
Implementation process
Plymouth Hospitals NHS Trust serves a population of
460,000, and extrapolating from this figure it is esti-
mated that there are about 4,500 patients with RA in
the PHNT catchment area. Initially, all patients attend-
ing routine review at PHNT will be assessed for eligibil-
ity. People with RA who are 18 years or over, have had
their disease for more than two years and are able to
initiate telephone contact if needed will be deemed eli-
gible. People will be excluded if they have no access to
a telephone, or are thought unable themselves or
through a relative or friend to initiate telephone contact
via the advice line when their disease requires clinical
review. All eligible patients will be educated about the
patient-initiated review system prior to their enrolment
into the system. However, due to the finite capacity of
education sessions per week, all eligible patients will
not be able to enroll into the system at once, and it will
take more than twelve months to educate all the
patients. Hence, we will use this timeframe as an oppor-
tunity to evaluate the new system of care against the
comparator traditional clinician-driven system using a
stepped-wedge study design. For this, a subgroup of
patients suitable to have their care transferred to the
patient-initiated review system will be randomised into
two groups using computer generated numbers. The
patients will either immediately enroll into the patient-
initiated review system (Direct Access group (DA)), or
will have regular clinician-initiated appointments (Regu-
lar Clinician initiated group (RC)) prior to transferring
to the patient-initiated review system.
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After randomisation, people in the DA group will be pro-
vided with an initial information sheet explaining the sys-
tem, and will be offered a choice of dates to attend a DA
patient education session over the following weeks. The
education sessions will comprise small groups of eight
people with RA led by a rheumatology specialist nurse,
and will focus on issues such as the operation of the DA
system, what patients can expect from the system, when
and how to call the advice line, when and how to ask for
appointments, and any other queries regarding the system
[2]. These patients will not be offered routine clinical re-
view, and their GP will be informed about this and sent a
short summary of managing common problems experi-
enced by people with established RA. Patients or their GP
can arrange prompt clinical advice and a review in clinic
where required by calling a rheumatology nurse-led advice
line where appointments can be accessed with a max-
imum delay of ten working days. The education session
was piloted on fifty patients and following the feedback
from the pilot session, changes were made before deliver-
ing it to the patients who are randomised. Any patients
declining entry to the DA system will continue to have
their care delivered through the traditional review system.
Regular clinician initiated group
The RC group will receive planned appointments at
regular intervals over the year prior to transferring to
DA at the end of the 12 months implementation process
(Figure 1). Patients in both groups who do not request
an appointment or who do not attend a routinely sched-
uled medical appointment over 12 months will be con-
tacted for a review by the rheumatology specialist nurse.
Implementation evaluation
The evaluation of the implementation process will
be undertaken collaboratively between the PHNTFigure 1 Flow diagram of the implementation trial study design.Rheumatology Department and the Collaboration of
Leadership and Applied Health Research and Care for
the South West Peninsula (PenCLAHRC). The study
will assess the following outcome measures.
Primary outcome measure
Patient satisfaction
As a surrogate of service quality, patient satisfaction will
be assessed at baseline and at the end of 12 months
using the Short-Form Patient Satisfaction Questionnaire
(PSQ-18) [14].
Secondary outcome measures
Service use
Number of visits to the rheumatology consultant,
rheumatology specialist nurse, physiotherapist and occu-
pational therapist will be recorded over the period of 12
months. In a random sample of 50 patients (25 from
each group), the cost of the total number of visits to
hospital rheumatologists, visits to GPs and allied health
professionals for problems related to arthritis and the
associated travel costs will be calculated using NHS trust
figures and published unit cost data [4].
Clinical measures
Clinical outcomes will be measured at baseline before
patients enter the DA system (during the education ses-
sion) and at the end of 12 months follow-up. Outcome
measures will include the RA disease activity score
(DAS-CRP), patient’s global opinion of disease activity
(10cm scale, measured from The London Handicap
Scale (LHS)), clinician’s global opinion of disease activity
(10cm scale, measured from LHS), pain over the preced-
ing 24 hours, early morning stiffness, tender joint count,
swollen joint count, disability (Health Assessment Ques-
tionnaire), C reactive protein (CRP), plasma viscosity
(PV), haemoglobin, rheumatoid factor (RF), rheumatoid
Paudyal et al. BMC Musculoskeletal Disorders 2012, 13:120 Page 4 of 5
http://www.biomedcentral.com/1471-2474/13/120factor titre (RFT), presence or absence of erosive disease
by most recent routine X-rays, and disease duration.
Waiting times
As the RC group will attend the clinician-initiated out-
patient clinic at regular intervals; service availability
upon request will be measured for the DA group only.
Waiting time will be assessed by calculating the number
of days from the advice line call to the medical
appointment.
Semi-structured, in-depth interviews will be carried
out with a subset of patients from both groups as
well as with the health professionals and administra-
tors involved in providing the service. Interviews will
particularly focus on assessing barriers and facilitators
of providing a patient-initiated service, reasons for
implementation success/failure, psychological benefits/
drawbacks and effects on wider life impacts, and per-
ceived or real changes in the interaction between patients
and the rheumatology team delivering their medical care.
All the interviews will be recorded and later transcribed.
Once all the transcripts have been analysed, a matrix will
be designed which will enable the emergence of major
themes and create an understanding of the individual
and group coding. The interviews will add depth to the
analysis of quantitative data and will be supplemented
through the observation of a sample of patient education
sessions given by a rheumatology specialist nurse. The
observation of these sessions will allow us to gather first-
hand information about the social processes between the
specialist rheumatology nurse and patients in an educa-
tional context. This will help inform the semi-structured
interviews as the qualitative researcher will have first-
hand knowledge of how patients were educated about
the new appointment system and what were their early
thoughts about such process change.
Sample size and statistical analysis
The assumptions underlying the sample size calculation
are derived from a published RCT [6]. In order to detect
a decrease in the number of consultations from 2.5 per
year in the RC group to 2 per year in the DA group at
the 5% significance level with 90% power to detect this
difference, we calculated that the current evaluation will
require 190 subjects in each group followed up for a
period of 12 months. Changes in other outcome mea-
sures between the two groups will be compared using
simple tests of association such as chi-squared (χ2) test
and Student’s t-test (depending on data properties). The
qualitative data analysis technique described by Miles
and Huberman [15] will be used to analyse the interview
data. This means affixing codes to a set of field notes
drawn from data collection and sorting through the
material to identify relationships between themes. Allinterview recordings will be transcribed and checked
for accuracy. The researcher will listen to the interview
recordings and make comments on the transcript and
read and re-read them to identify relevant codes. Once
all transcripts have been analysed in this way a matrix
will be designed which will enable the emergence of
major themes and create an understanding of the indi-
vidual and group coding. Computer aided software
such as NVivo (a qualitative data analysis tool that
helps to organise and analyse unstructured, i.e. non-
numerical data) will be used to interrogate the data at
different levels.
Discussion
The implementation of the DA system in Plymouth will
move the service provision from a traditional clinician-
driven review system to a more flexible patient-driven
system where patients can request help according to
their needs. Our evaluation will provide routinely col-
lected data enabling an assessment of the impact of
implementing this type of service change in the National
Health Service. In addition, the qualitative analysis will
offer insights into the reasons why such a service imple-
mentation might be successful, and how both health
staff and patients perceive both the benefits and draw-
backs of such a change.
In the current evaluation we will be able to compare
the changes in local services and inform local patients,
commissioners and providers about the changes in
rheumatology service provision. In the context of a pre-
vious RCT, the DA system was established as being
more cost-effective, providing greater satisfaction to
patients, GPs and rheumatologists, and reduced the
delay in follow-up appointments compared with the
traditional review system [6]. However RCTs cannot give
evidence of how such a service change impacts on the
delivery of healthcare in a routine setting. Our expect-
ation is that this implementation of a patient-initiated
system of care will reduce unnecessary appointments
and costs, be more responsive to patients when they
need rapid help, and through these processes empower
patients to improve their own self-care. In the current fi-
nancial climate it will be informative to see if these
expectations are realised.
Ethical approval
After advice from the National Research Ethics Service
South-West (Bristol), UK, the quantitative and qualita-
tive evaluations planned for this process do not require
full, NHS ethical approval as is it an evaluation of a
change in service. However, all interview respondents
(both patients and professionals) will be volunteers and
will all be provided with a detailed information sheet
which describes the nature of the study. Written,
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dised consent form. Confidentiality will be emphasised at
the outset and interview transcripts will be anonymised.
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